Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Specific focus on clinical cardiovascular pharmacology
Pharmacology is an extremely important part of cardiology today. Nearly every patient with cardiac disease is on some kind of medication. Already there are almost half a million references to ‘cardiovascular pharmacology’ in MEDLINE and the number of papers within this area is growing very fast. More studies are needed to improve outcomes of patients with cardiovascular disease, which is the most common cause of death globally.
The official journal of the ESC Working Group on Cardiovascular Pharmacotherapy and a brand new addition to the ESC Journal Family, EHJ - Cardiovascular Pharmacotherapy aims to publish reports specifically describing clinical research relevant to cardiovascular drug therapy.
Submit your paper
Visit the journal's home page
ISSN 2055-6837Volume 2 - year 20164 issues
Combined (print & online): €40
Members of Working Group on Cardiovascular Pharmacotherapy Combined (print & online): €30
Professor Stefan Agewall, (NO), MD PhD, FESC, FACC, is senior consultant and professor of cardiology at Oslo University Hospital. More than 170 peer-reviewed publications in the cardiovascular field. Chairman of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology 2014-2016. Senior Consulting Editor of the European Heart Journal. Board member of the European Society of Cardiology Committee for Practice Guidelines and Editorial board member of the European Heart Journal.
An expert and respected editorial board has been recruited from across the globe, including:Angeles Alonso, SpainJeroen J Bax, the NetherlandsJohn Beltrame, AustraliaDeepak L. Bhatt, USEugene Braunwald, USJohn Camm, UKRobin Choudhury, UKRaffaele De Caterina, ItalyClaudio Ceconi, ItalyRobert Doughty, New ZealandHeinz Drexel, AustriaPasquale Perrone Filardi, ItalyGerasimos Filippatos, GreeceChristian Funck-Brentano, FranceWolfgang-Michael Franz, AustriaEvangelos Giannitsis, GermanyRobert P Giugliano, USShinya Goto, JapanStefan Hohnloser, GermanyBernard Gersh, USChris Granger, USSteen Husted, DenmarkStefan James, SwedenJuan Carlos Kaski, UKJohn J.P. Kastelein, the NetherlandsSverre Kjeldsen, NorwayGregory Lip, UKAlexander Niessner, AustriaLionel Opie, South AfricaAtul Pathak, FranceFausto Pinto, PortugalBertram Pitt, USGuiseppe Rosano, UKLuis Ruilope, SpainMarc S. Sabatine, USRaul Santos, BrazilGaetano Santulli, USHarald Schmidt, the NetherlandsUdo Sechtem, GermanyTabassome Simon, FrancePhilippe Gabriel Steg, FranceJuan Tamargo, SpainChristian Torp Pedersen, DenmarkHung-Fat Tse, Hong Kong ChinaWiek H van Gilst, the NetherlandsThomas Walther, IrelandMorten Wang Fagerlund, NorwaySven Wassmann, GermanyPetr Widimsky, Czech RepublicHarvey White, New ZealandJosé Luis Zamorano, SpainFaiez Zannad, France
© 2017 European Society of Cardiology. All rights reserved